Background: Post-ablation atrial fibrillation (AF) inducibility has been associated with AF recurrence and is often used as an endpoint for Pulmonary Vein Isolation (PVI). Little is known regarding ...

Background: The majority of non-pulmonary vein (PV) triggers of atrial fibrillation (AF) require provocative maneuvers for induction during catheter ablation. Identifying a subset of patients with ...

Varicose veins and inflammation-related clotting (thrombophlebitis) are the most common concerns. Treatments range from lifestyle adjustments and compression stockings to options like sclerotherapy or ...

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

You may also have physical therapy appointments for more serious ablation procedures like cardiac or brain ablations. Endometrial and bladder ablations, or more superficial ablations for issues like ...

Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

the first pulsed field ablation device approved by the FDA back in December 2023, will continue to provide a single-shot solution for isolating the pulmonary vein, while Affera and Sphere-9 will ...

Rate and rhythm control along with stroke prophylaxis are the cornerstones of AF therapy. With the recent evolution of techniques, AF ablation is becoming the first therapeutic option in many centres ...